Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anrad Corporation was a specialized medical technology firm focused on the development of advanced digital X-ray detectors. Based in Montreal, Canada, the company pioneered the use of amorphous selenium (a-Se) for direct-conversion imaging, a technology that provides superior clarity and resolution for medical diagnostics. Their primary applications included digital mammography, where high-precision imaging is critical for early cancer detection, and general radiography. Anrad operated as a joint venture between Noranda Inc. and the Quebec government before being acquired by Analogic Corporation in 2003. Following the acquisition, Anrad's technology became a cornerstone of Analogic's digital radiography business unit. The company's innovations significantly contributed to the industry's transition from film-based to digital medical imaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anrad.